Trial Profile
Impact of Interferon-Free Direct-Acting Antivirals on Thyroid dysfunction in Patients Infected with Hepatitis C Virus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2018
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary) ; Ledipasvir (Primary) ; Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacodynamics
- 10 Dec 2018 New trial record
- 13 Nov 2018 Results presented at The Liver Meeting 2018: 69th Annual Meeting of the American Association for the Study of Liver Diseases